ICU Medical, Inc. (NASDAQ:ICUI) Shares Purchased by Swiss National Bank

Swiss National Bank grew its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 0.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 45,619 shares of the medical instruments supplier’s stock after purchasing an additional 400 shares during the quarter. Swiss National Bank owned 0.19% of ICU Medical worth $7,079,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Barclays PLC raised its position in ICU Medical by 15.6% in the third quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier’s stock worth $10,790,000 after acquiring an additional 8,010 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of ICU Medical by 24.6% in the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock worth $23,130,000 after purchasing an additional 25,031 shares in the last quarter. MetLife Investment Management LLC lifted its stake in ICU Medical by 129.1% during the third quarter. MetLife Investment Management LLC now owns 12,389 shares of the medical instruments supplier’s stock valued at $2,258,000 after purchasing an additional 6,981 shares during the last quarter. Jennison Associates LLC bought a new stake in ICU Medical during the fourth quarter worth approximately $556,000. Finally, Geode Capital Management LLC grew its position in ICU Medical by 9.6% in the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock worth $99,687,000 after buying an additional 48,106 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

Insiders Place Their Bets

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the transaction, the chief executive officer now owns 104,593 shares in the company, valued at approximately $16,262,119.64. This represents a 1.30 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Stock Performance

Shares of ICUI stock opened at $147.07 on Friday. The company has a market capitalization of $3.61 billion, a price-to-earnings ratio of -32.18 and a beta of 0.73. ICU Medical, Inc. has a 1-year low of $93.36 and a 1-year high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The stock’s fifty day simple moving average is $156.08 and its 200-day simple moving average is $164.41.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective for the company in a research note on Wednesday, December 11th. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, March 18th. Finally, Raymond James set a $97.00 price objective on ICU Medical in a report on Wednesday, March 12th. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $168.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.